CA2203632A1 - A chitosan polymer having a specific degree of acetylation - Google Patents

A chitosan polymer having a specific degree of acetylation

Info

Publication number
CA2203632A1
CA2203632A1 CA 2203632 CA2203632A CA2203632A1 CA 2203632 A1 CA2203632 A1 CA 2203632A1 CA 2203632 CA2203632 CA 2203632 CA 2203632 A CA2203632 A CA 2203632A CA 2203632 A1 CA2203632 A1 CA 2203632A1
Authority
CA
Canada
Prior art keywords
chitosan
acetylation
chitosans
degree
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2203632
Other languages
English (en)
French (fr)
Inventor
Nicolaas Schipper
Per Artursson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2203632A1 publication Critical patent/CA2203632A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA 2203632 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation Abandoned CA2203632A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9403905-4 1994-11-14
SE9403905A SE9403905D0 (sv) 1994-11-14 1994-11-14 New formulations
PCT/SE1995/001342 WO1996020730A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation

Publications (1)

Publication Number Publication Date
CA2203632A1 true CA2203632A1 (en) 1996-07-11

Family

ID=20395954

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2203632 Abandoned CA2203632A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation

Country Status (9)

Country Link
EP (1) EP0792330A1 (ja)
JP (1) JPH10509207A (ja)
AU (1) AU710769B2 (ja)
CA (1) CA2203632A1 (ja)
FI (1) FI972056A (ja)
IS (1) IS4469A (ja)
NO (1) NO972172D0 (ja)
SE (1) SE9403905D0 (ja)
WO (1) WO1996020730A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
US20020018732A1 (en) * 2000-04-21 2002-02-14 Hung William M. Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US20060287278A1 (en) * 2005-06-21 2006-12-21 Zhenze Hu Method for improving water solubility of chitosan
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
EP3034612A1 (en) * 2014-12-16 2016-06-22 Greenaltech, S.L. Chitin and chitosan producing methods
EP3372234B1 (en) * 2015-11-04 2021-09-29 Stelic Institute & Co., Inc. Complex comprising rnai molecule and n-acetylated chitosan
WO2024054707A2 (en) 2022-09-08 2024-03-14 Luna Labs Usa, Llc Layer-by-layer delivery of active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873092A (en) * 1987-05-21 1989-10-10 Murata Kikai Kabushiki Kaisha Slow-releasing preparation
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions

Also Published As

Publication number Publication date
JPH10509207A (ja) 1998-09-08
FI972056A0 (fi) 1997-05-14
IS4469A (is) 1997-04-22
SE9403905D0 (sv) 1994-11-14
FI972056A (fi) 1997-05-14
WO1996020730A1 (en) 1996-07-11
NO972172L (no) 1997-05-12
AU710769B2 (en) 1999-09-30
EP0792330A1 (en) 1997-09-03
NO972172D0 (no) 1997-05-12
AU3943395A (en) 1996-07-24

Similar Documents

Publication Publication Date Title
Van der Merwe et al. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs
Kulkarni et al. Xyloglucan: A functional biomacromolecule for drug delivery applications
Singhvi et al. Xanthan gum in drug delivery applications
Cortes et al. Xanthan gum in drug release
Kumar et al. Chitosan chemistry and pharmaceutical perspectives
Dodane et al. Pharmaceutical applications of chitosan
Singla et al. Chitosan: Some pharmaceutical and biological aspects‐an update
Hejazi et al. Chitosan-based gastrointestinal delivery systems
Di Colo et al. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin
US7883723B2 (en) Water soluble chitosan nanoparticle for delivering an anticancer agent and preparing method thereof
RU2424793C2 (ru) Фармацевтическая композиция, включающая диклофенак
JP4648632B2 (ja) 新規バイオマテリアル、その製造および使用
EP1126881B1 (de) Mucoadhäsive polymere, deren verwendung sowie deren herstellungsverfahren
EP2360188A1 (en) Hyaluronic acid derivative and pharmaceutical composition thereof
FR2919188A1 (fr) Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps
Noreen et al. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery
EA010351B1 (ru) Доставка физиологических агентов in situ при помощи гелей, включающих анионные полисахариды
AU6219599A (en) Formulations of fexofenadine
AU710769B2 (en) A chitosan polymer having a specific degree of acetylation
EP3442510A1 (en) Anti-infective compositions comprising phytoglycogen nanoparticles
Ricci et al. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery
Ugoeze Bioadhesive polymers for drug delivery applications
Hejazi et al. Chitosan-based delivery systems: Physicochemical properties and pharmaceutical applications
CN111732675A (zh) 透明质酸-氨基葡萄糖接枝共聚物、制法及其应用
Vibhooti et al. Eudragit and chitosan—The two most promising polymers for colon drug delivery

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead